DEAGE Trademark

Trademark Overview

On Wednesday, February 11, 2026, a trademark application was filed for DEAGE with the United States Patent and Trademark Office. The USPTO has given the DEAGE trademark a serial number of 99647697. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, February 11, 2026. This trademark is owned by MDTB Cells GmbH. The DEAGE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Sepsis, Septic Shock, bacterial skin and tissue Infections, fungal skin and tissue Infections, viral skin and tissue Infections, parasitic skin and tissue infections, Pneumonia, Acute Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Osteoarthritis, osteoarthritis of the knee, osteoarthritis of the hip, osteoarthritis of the shoulder, other osteoarthroses, degenerative disc disease, namely, intervertebral disc degeneration, Alzheimer’s disease; Pharmaceutical preparations for the treatment of Parkinson’s disease, Neonatal Stroke, Neonatal Sepsis, Intraventricular Hemorrhage, Ischemic Stroke, Hemorrhagic Stroke, Perioperative Myocardial Infarction, heart failure, chronic kidney disease, Chronic Obstructive Pulmonary Disease (COPD), idiopathic pulmonary fibrosis, diabetic foot ulcers, type 1 diabetes mellitus, Graft versus Host Disease (GvHD), rheumatoid arthritis, ankylosing spondylitis, m...
deage

General Information

Serial Number99647697
Word MarkDEAGE
Filing DateWednesday, February 11, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, February 11, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of Sepsis, Septic Shock, bacterial skin and tissue Infections, fungal skin and tissue Infections, viral skin and tissue Infections, parasitic skin and tissue infections, Pneumonia, Acute Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Osteoarthritis, osteoarthritis of the knee, osteoarthritis of the hip, osteoarthritis of the shoulder, other osteoarthroses, degenerative disc disease, namely, intervertebral disc degeneration, Alzheimer’s disease; Pharmaceutical preparations for the treatment of Parkinson’s disease, Neonatal Stroke, Neonatal Sepsis, Intraventricular Hemorrhage, Ischemic Stroke, Hemorrhagic Stroke, Perioperative Myocardial Infarction, heart failure, chronic kidney disease, Chronic Obstructive Pulmonary Disease (COPD), idiopathic pulmonary fibrosis, diabetic foot ulcers, type 1 diabetes mellitus, Graft versus Host Disease (GvHD), rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, psoriasis, perianal fistulas associated with Crohn’s disease; Medicinal preparations for the treatment of Sepsis, Septic Shock, bacterial skin and tissue Infections, fungal skin and tissue Infections, viral skin and tissue Infections, parasitic skin and tissue infections, Pneumonia, Acute Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Osteoarthritis, osteoarthritis of the knee, osteoarthritis of the hip, osteoarthritis of the shoulder, other osteoarthroses; Medicinal preparations for degenerative disc disease, namely, intervertebral disc degeneration, Alzheimer’s disease, Parkinson’s disease, Neonatal Stroke, Neonatal Sepsis, Intraventricular Hemorrhage, Ischemic Stroke, Hemorrhagic Stroke, Perioperative Myocardial Infarction, heart failure, chronic kidney disease; Medicinal preparations for Chronic Obstructive Pulmonary Disease (COPD), idiopathic pulmonary fibrosis, diabetic foot ulcers, type 1 diabetes mellitus, Graft versus Host Disease (GvHD), rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, psoriasis, perianal fistulas associated with Crohn’s disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 11, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMDTB Cells GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressRadebeul 01445
DE

Trademark Events

Event DateEvent Description
Wednesday, February 11, 2026NEW APPLICATION ENTERED
Wednesday, February 11, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 11, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

deage disease skin osteoarthritis infections tissue chronic stroke pharmaceutical disc preparations